Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
16.80
-0.25 (-1.47%)
Nov 19, 2026, 4:00 PM EST - Market closed
Tandem Diabetes Care Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Upgrades $22 → $26 | Buy | Upgrades | $22 → $26 | +54.76% | Nov 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $40 | Buy | Maintains | $40 | +138.10% | Nov 16, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 7, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $27 → $25 | Buy | Maintains | $27 → $25 | +48.81% | Nov 6, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $22 | Buy | Maintains | $22 | +30.95% | Nov 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $26 | Buy | Maintains | $26 | +54.76% | Nov 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $33 | Buy | Reiterates | $33 | +96.43% | Nov 6, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +19.05% | Nov 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.